Your browser doesn't support javascript.
loading
A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approaches.
Negahdaripour, Manica; Eslami, Mahboobeh; Nezafat, Navid; Hajighahramani, Nasim; Ghoshoon, Mohammad Bagher; Shoolian, Eskandar; Dehshahri, Ali; Erfani, Nasrollah; Morowvat, Mohammad Hossein; Ghasemi, Younes.
Afiliação
  • Negahdaripour M; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; Pharmaceutical Sciences Research Center, Shiraz University of Medical Science, Shiraz, Iran.
  • Eslami M; Pharmaceutical Sciences Research Center, Shiraz University of Medical Science, Shiraz, Iran.
  • Nezafat N; Pharmaceutical Sciences Research Center, Shiraz University of Medical Science, Shiraz, Iran.
  • Hajighahramani N; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; Pharmaceutical Sciences Research Center, Shiraz University of Medical Science, Shiraz, Iran.
  • Ghoshoon MB; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; Pharmaceutical Sciences Research Center, Shiraz University of Medical Science, Shiraz, Iran.
  • Shoolian E; Charité University of Medicine, Campus Research House of Clinical Chemistry and Biochemistry, Augustenburger Platz 1, 13353 Berlin, Germany; Biotechnology Incubator Center, Shiraz University of Medical Science, Shiraz, Iran.
  • Dehshahri A; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; Pharmaceutical Sciences Research Center, Shiraz University of Medical Science, Shiraz, Iran.
  • Erfani N; Cancer Immunology Group, Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Morowvat MH; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; Pharmaceutical Sciences Research Center, Shiraz University of Medical Science, Shiraz, Iran.
  • Ghasemi Y; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; Pharmaceutical Sciences Research Center, Shiraz University of Medical Science, Shiraz, Iran; Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies,
Infect Genet Evol ; 54: 402-416, 2017 10.
Article em En | MEDLINE | ID: mdl-28780192
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Proteínas Oncogênicas Virais / Biologia Computacional / Vacinas de Subunidades Antigênicas / Proteínas do Capsídeo / Vacinas contra Papillomavirus Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Infect Genet Evol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Proteínas Oncogênicas Virais / Biologia Computacional / Vacinas de Subunidades Antigênicas / Proteínas do Capsídeo / Vacinas contra Papillomavirus Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Infect Genet Evol Ano de publicação: 2017 Tipo de documento: Article